Showing results (1-10 of 53) with videos related to
Sort By:
Pageof 6
Biochemistry|October 9, 2019
The Road Ahead for the Development of Macrocyclic Peptide LigandsToby PassiouraChemistry (Weinheim an Der Bergstrasse, Germany)|March 23, 2013
Flexizyme-mediated genetic reprogramming as a tool for noncanonical peptide synthesis and drug discoveryToby Passioura, Hiroaki SugaTopics in Current Chemistry|March 13, 2013
Flexizymes, their evolutionary history and diverse utilitiesToby Passioura, Hiroaki SugaChemical Communications (Cambridge, England)|January 17, 2017
A RaPID way to discover nonstandard macrocyclic peptide modulators of drug targetsToby Passioura, Hiroaki SugaTrends in Biochemical Sciences|August 18, 2014
Reprogramming the genetic code in vitroToby Passioura, Hiroaki SugaSynthetic Biology (Oxford, England)|September 30, 2020
Advances in <i>in vitro</i> genetic code reprogramming in 2014-2017Takayuki Katoh, Toby Passioura, Hiroaki SugaMolecules (Basel, Switzerland)|March 20, 2013
Technologies for the synthesis of mRNA-encoding libraries and discovery of bioactive natural product-inspired non-traditional macrocyclic peptidesKenichiro Ito, Toby Passioura, Hiroaki SugaExpert Opinion on Drug Discovery|June 14, 2024
The coming of age of cyclic peptide drugs: an update on discovery technologiesSophia You, Glen McIntyre, Toby PassiouraCancer Research|February 12, 2005
N-ras-induced growth suppression of myeloid cells is mediated by IRF-1Toby Passioura, Alla Dolnikov, Sylvie Shen, et al.Biomedicines|December 16, 2018
Structural Features and Binding Modes of Thioether-Cyclized Peptide LigandsManuel E Otero-Ramirez, Toby Passioura, Hiroaki SugaPageof 6